Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery

References

• American Cancer SocietyCancer Facts And Figures, 2008OaklandAmerican Society2008216
   Google Scholar
• MailletACongy-JolivetNLe GuellecSAerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulizationPharm Res2008251318132618030605
   PubMed Web of Science ®Google Scholar
• MyrdalGLambergKLambeMRegional differences in treatment and outcome in non-small cell lung cancer: A population-based studyLung Cancer200963162218571760
   PubMed Web of Science ®Google Scholar
• ProvencioMCampsCAlberolaVLung cancer and treatment in elderly patients: The Achilles StudyLung Cancer20096610310619193470
   PubMed Web of Science ®Google Scholar
• GagnadouxFPapeALLemarieEAerosol delivery of chemotherapy in an orthotopic model of lung cancerEur Respir J20052665766116204597
   PubMed Web of Science ®Google Scholar
• HersheyAEKurzmanIDForrestLJInhalation chemotherapy for macroscopic primary or metastatic lung tumors: Proof of principle using dogs with spontaneously occurring tumors as a modelClin Cancer Res199952653265910499645
   PubMed Web of Science ®Google Scholar
• LipworthBJPharmacokinetics of inhaled drugsBr J Pharmacol199642697706
   Web of Science ®Google Scholar
• HeYCChenJWCaoJToxicities and therapeutic effect of 5-fluorouracil controlled release implant on tumor-bearing ratsWorld J Gastroenterol200391795179812918123
   PubMed Web of Science ®Google Scholar
• YanoTYamazakiKMaruyamaRFeasibility study of postoperative adjuvant chemotherapy with S-1 (tegaful, gimeracil, oteracil potassium) for non-small cell lung cancer – LOGIK 0601 studyLung Cancer20106718418719409643
   PubMed Web of Science ®Google Scholar
• SharmaSWhiteDImondiARDevelopment of inhalational agents for oncologic useJ Clin Oncol2001191839184711251016
   PubMed Web of Science ®Google Scholar
• HitzmanCJElmquistWFWattenbergLWDevelopment of a respirable, sustained release nicrocarrier for 5-fluorouracil I: In-vitro assessment of liposomes, microspheres, and lipid coated nanoparticlesJ Pharm Sci2006951114112616570302
   PubMed Web of Science ®Google Scholar
• HitzmanCJWattenbergLWWiedmannTSPharmacokinetics of 5-fluorouracil in the hamster following inhalation delivery of lipid-coated nanoparticlesJ Pharm Sci2006951196121116639722
   PubMed Web of Science ®Google Scholar
• HitzmanCJElmquistWFWiedmannTSDevelopment of a respirable, sustained release microcarrier for 5-fluorouracil II: In-vitro and in vivo optimization of lipid coated nanoparticlesJ Pharm Sci2006951127114316570303
   PubMed Web of Science ®Google Scholar
• BaileyMMBerklandCJNanoparticle formulations in pulmonary drug deliveryMed Res Rev20092919621218958847
   PubMed Web of Science ®Google Scholar
• DhumalRSBiradarSVParadkarARParticle engineering using sonocrystallization: Salbutamol sulphate for pulmonary deliveryInt J Pharm200938612913718996462
   PubMed Web of Science ®Google Scholar
• ShariatiAPetersCJRecent developments in particle design using supercritical fluidsCurr Opin Solid State Mater Sci20037371383
   Web of Science ®Google Scholar
• GintyJWhitakerMJShakesheffKMDrug delivery goes supercriticalMaterials Today200584248
   Web of Science ®Google Scholar
• KimMJinSKimJPreparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical anti-solvent (SAS) processEur J Pharm Pharmacol200869454465
   Google Scholar
• NajafabadiARVatanaraAGilaniKFormation of salbutamol sulphate microparticles using solution enhanced dispersion by supercritical carbon dioxideDARU20051316
   Google Scholar
• VatanaraANajafabadiARGilaniKADesign for screening of the operational variables in the formation of salbutamol sulphate particles by supercritical anti-solventJ Supercritical Fluids200740111116
   Web of Science ®Google Scholar
• ZengXMTeeSKMartinGPEffect of mixing procedure and particle size distribution of the carrier particle on the deposition of salbutamol sulphate from dry powder inhaler formulationsProceedings of Drug Delivery to the Lungs VIILondonThe Aerosol Society1996
   Google Scholar
• GiryKPeanJMGiraudLDrug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalationInt J Pharm200632116216616797150
   PubMed Web of Science ®Google Scholar
• LucasPClarkeMJAndersonKTobynMJStaniforthJNDalbyRNByronPRFarrSTThe role of fine particle excipients in pharmaceutical dry powder aerosolsRespiratory Drug DeliveryBuffalo Grove, ILInterpharm Press Inc1998
   Google Scholar
• YoungSTrainiDJonesMDThe influence of dose on the performance of dry powder inhalation systemsInt J Pharm2005296263315885452
   PubMed Web of Science ®Google Scholar
• GallagherPMCoffeyMPKrukonisVJJohnstonKPenningerJGas antisolvent recrystallization: New process to recrystallize compounds insoluble in supercritical fluidsACS Symposium Series 406. Supercritical Fluid Science and TechnologyWashington, DCAmerican Chemical Society1989
   Google Scholar
• DukhinSSShenYDaveRDroplet mass transfer, intradroplet nucleation and submicron particle production in two-phase flow of solvent-supercritical antisolvent emulsionColl Surf A2005261163176
   Web of Science ®Google Scholar
• StievanoMElvassoreNHigh-pressure density and vapor-liquid equilibrium for the binary systems carbon dioxide-ethanol, carbon dioxide-acetone and carbon dioxide-dichloromethaneJ Supercritical Fluids200533714
   Web of Science ®Google Scholar
• GeiserMSchurchSGehrPInfluence of surface chemistry and topography of particles on their immersion into the lung’s surface-lining layerJ Appl Physiol2003941793180112547838
   PubMed Web of Science ®Google Scholar
• WattenbergLWWiedmannTSEstensenRDChemoprevention of cancer of the upper respiratory tract of the Syrian golden hamster by aerosol administration of difluoromethylornithine and 5-fluorouracilCancer Res2004642347234915059884
   PubMed Web of Science ®Google Scholar
• TatsumuraTKTsujimotoMKitagawaMFurther study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: Fundamental and clinicalBr J Cancer199368114611498260366
   PubMed Web of Science ®Google Scholar
• HwangSMKimDDChungSJDelivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosisJ Control Release200812910010618538437
   PubMed Web of Science ®Google Scholar
• ByronPRPrediction of drug residence time in regions of the human respiratory tract following aerosol inhalationJ Pharm Sci1986754334383735078
   PubMed Web of Science ®Google Scholar
• CourrierHMButzNVandammeTFPulmonary drug delivery systems: Recent developments and prospectsCrit Rev Ther Drug Carrier Syst20021942549812661699
   PubMed Web of Science ®Google Scholar
• CorriganDOCorriganOIHealyAMPhysicochemical and in-vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalersInt J Pharm2006322223016815654
   PubMed Web of Science ®Google Scholar
• YangaWPetersJIWilliamsROInhaled nanoparticles – A current reviewInt J Pharm200835623924718358652
   PubMed Web of Science ®Google Scholar